鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/08/04 | 3,530 | 3,530 | 3,465 | 3,485 | -45 | -1.3% | 27,300 |
| 2023/08/03 | 3,580 | 3,600 | 3,530 | 3,530 | -100 | -2.8% | 31,500 |
| 2023/08/02 | 3,630 | 3,665 | 3,580 | 3,630 | -5 | -0.1% | 44,800 |
| 2023/08/01 | 3,655 | 3,675 | 3,585 | 3,635 | +25 | +0.7% | 25,700 |
| 2023/07/31 | 3,625 | 3,650 | 3,575 | 3,610 | +55 | +1.5% | 31,200 |
| 2023/07/28 | 3,545 | 3,590 | 3,545 | 3,555 | -20 | -0.6% | 46,800 |
| 2023/07/27 | 3,540 | 3,575 | 3,535 | 3,575 | +40 | +1.1% | 10,200 |
| 2023/07/26 | 3,535 | 3,555 | 3,520 | 3,535 | -15 | -0.4% | 13,800 |
| 2023/07/25 | 3,595 | 3,605 | 3,535 | 3,550 | -35 | -1% | 21,700 |
| 2023/07/24 | 3,555 | 3,600 | 3,530 | 3,585 | +55 | +1.6% | 17,700 |
| 2023/07/21 | 3,560 | 3,565 | 3,515 | 3,530 | -5 | -0.1% | 29,900 |
| 2023/07/20 | 3,605 | 3,610 | 3,530 | 3,535 | -70 | -1.9% | 29,200 |
| 2023/07/19 | 3,560 | 3,605 | 3,550 | 3,605 | +105 | +3% | 31,400 |
| 2023/07/18 | 3,545 | 3,555 | 3,490 | 3,500 | -30 | -0.8% | 18,600 |
| 2023/07/14 | 3,500 | 3,550 | 3,490 | 3,530 | +10 | +0.3% | 52,800 |
| 2023/07/13 | 3,500 | 3,535 | 3,485 | 3,520 | +20 | +0.6% | 38,000 |
| 2023/07/12 | 3,565 | 3,565 | 3,500 | 3,500 | -35 | -1% | 29,000 |
| 2023/07/11 | 3,565 | 3,575 | 3,535 | 3,535 | -20 | -0.6% | 28,000 |
| 2023/07/10 | 3,650 | 3,650 | 3,555 | 3,555 | -65 | -1.8% | 42,800 |
| 2023/07/07 | 3,590 | 3,640 | 3,580 | 3,620 | +5 | +0.1% | 67,500 |
| 2023/07/06 | 3,645 | 3,645 | 3,600 | 3,615 | +5 | +0.1% | 47,200 |
| 2023/07/05 | 3,590 | 3,620 | 3,575 | 3,610 | -30 | -0.8% | 47,200 |
| 2023/07/04 | 3,630 | 3,670 | 3,600 | 3,640 | +10 | +0.3% | 51,400 |
| 2023/07/03 | 3,635 | 3,665 | 3,615 | 3,630 | +10 | +0.3% | 39,600 |
| 2023/06/30 | 3,655 | 3,675 | 3,605 | 3,620 | -35 | -1% | 47,000 |
| 2023/06/29 | 3,580 | 3,685 | 3,580 | 3,655 | -20 | -0.5% | 49,300 |
| 2023/06/28 | 3,675 | 3,700 | 3,635 | 3,675 | ±0 | ±0% | 92,700 |
| 2023/06/27 | 3,615 | 3,685 | 3,615 | 3,675 | +5 | +0.1% | 25,900 |
| 2023/06/26 | 3,605 | 3,680 | 3,590 | 3,670 | +45 | +1.2% | 40,200 |
| 2023/06/23 | 3,670 | 3,670 | 3,615 | 3,625 | -15 | -0.4% | 28,200 |
| 2023/06/22 | 3,645 | 3,655 | 3,625 | 3,640 | +10 | +0.3% | 30,300 |
| 2023/06/21 | 3,680 | 3,680 | 3,625 | 3,630 | -25 | -0.7% | 36,700 |
| 2023/06/20 | 3,655 | 3,665 | 3,620 | 3,655 | -5 | -0.1% | 21,000 |
| 2023/06/19 | 3,715 | 3,730 | 3,640 | 3,660 | +15 | +0.4% | 38,300 |
| 2023/06/16 | 3,630 | 3,660 | 3,600 | 3,645 | +35 | +1% | 69,100 |
| 2023/06/15 | 3,620 | 3,645 | 3,590 | 3,610 | -25 | -0.7% | 34,100 |
| 2023/06/14 | 3,655 | 3,655 | 3,610 | 3,635 | -20 | -0.5% | 38,200 |
| 2023/06/13 | 3,640 | 3,665 | 3,630 | 3,655 | +15 | +0.4% | 49,700 |
| 2023/06/12 | 3,695 | 3,715 | 3,640 | 3,640 | -65 | -1.8% | 44,600 |
| 2023/06/09 | 3,720 | 3,720 | 3,630 | 3,705 | +75 | +2.1% | 79,000 |
| 2023/06/08 | 3,550 | 3,665 | 3,550 | 3,630 | +115 | +3.3% | 99,500 |
| 2023/06/07 | 3,560 | 3,565 | 3,500 | 3,515 | -30 | -0.8% | 39,200 |
| 2023/06/06 | 3,550 | 3,555 | 3,510 | 3,545 | -5 | -0.1% | 35,700 |
| 2023/06/05 | 3,550 | 3,590 | 3,500 | 3,550 | +95 | +2.7% | 73,800 |
| 2023/06/02 | 3,400 | 3,465 | 3,400 | 3,455 | +45 | +1.3% | 23,000 |
| 2023/06/01 | 3,430 | 3,515 | 3,395 | 3,410 | +35 | +1% | 63,900 |
| 2023/05/31 | 3,425 | 3,445 | 3,350 | 3,375 | -80 | -2.3% | 99,600 |
| 2023/05/30 | 3,365 | 3,475 | 3,330 | 3,455 | +110 | +3.3% | 82,000 |
| 2023/05/29 | 3,445 | 3,445 | 3,340 | 3,345 | -40 | -1.2% | 13,800 |
| 2023/05/26 | 3,405 | 3,425 | 3,380 | 3,385 | -20 | -0.6% | 19,100 |
201～
250
件表示中 / 3467件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 378,500円 | +7.3% | +16.8% | 3.17% | 22.64倍 | 0.89倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| 杏林製薬 | 171,500円 | +3.2% | +4.5% | 3.03% | 19.71倍 | 0.75倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ジーエヌアイ | 220,300円 | +52.1% | +23.3% | 0.00% | 15.60倍 | 3.26倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| ゼリア新薬 | 198,700円 | +9.6% | +17.5% | 2.32% | 11.23倍 | 1.10倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 209,700円 | +7.6% | +57.5% | 2.53% | 16.19倍 | 1.59倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
